Managing DirectorLondon Mergers & Acquisitions Healthcare email@example.com +44 20 8126 5130
I strive to build long-term relationships with key individuals in my sectors of focus in order to provide the best advisory services for my clients.
As a member of the firm’s Healthcare Group, James advises mid-market company owners and investors on mergers and acquisitions (M&A). His focus spans the pharmaceutical and pharmaceutical services sectors, advising on both buy-sides and sell-sides. Specifically, he has advised on transactions covering the commercial, manufacturing and research; pharmaceutical products and generics and medical technology, devices and diagnostics sectors.
Over almost a decade in the industry, James has built up a network and is passionate in helping shape growth strategies for company owners.
Prior to joining Lincoln, James worked at Results International where he led the pharmaceutical services practice. Previously, he worked at KPMG in the healthcare M&A team.
James holds a Master of Pharmacy from Bath University and is a qualified Associate Chartered Accountant.
Lincoln International has advised LGC on the sale of DDS to Alliance Pharma, a portfolio company of Ampersand and KKR
Lincoln International is pleased to announce that ARK Agency has been sold to OPEN Health, a portfolio company of Amulet Capital Partners
Lincoln International is pleased to announce that OPEN Health, a portfolio company of Amulet Capital Partners, has acquired Spirit Medical Communications
Perspectives featuring James West
Lincoln’s Latest video series features experts from across industries, services and geographies, sharing perspectives on current trends, recent observations and future outlooks.
Discovering the Investment Opportunity in Pre-Clinical CROs
The process to bring a drug to market is likely to be extensive and costly, from the starting points of research and development (R&D) across all phases of clinical trials… Read More
Global Supply Chain Volatility: 2022 Outlook
Amidst historic production disruption, shortages and low levels of inventory, manufacturers, distributors and retailers have been adapting business strategy real-time in response to continued volatility. There has been a rising… Read More
Q&A with Lincoln Healthcare Director James West: The Future of UK Pharma Services and Manufacturing
Lincoln International recently welcomed James West, a London-based Director in the firm’s global Healthcare Group. With a unique background as a pharmacist turned life sciences investment banker, James joins Lincoln… Read More
News & Media featuring James West
Real Deals | Healthcare M&A Resilience
What trends have you seen in the last quarter in relation to valuations in the healthcare space? Matthew Lee: It’s early days to get an accurate read on valuations as… Read More
Lincoln International Announces Managing Director Promotions 2022
Lincoln International, a global investment banking advisory firm, is pleased to announce the promotion of six Directors to Managing Director (MD), effective January 1, 2023. “Each of these individuals contributes… Read More
In Vivo Pharma Intelligence | The Growth Path for Drug Discovery Partners
Originally published by In Vivo Pharma Intelligence on November 15, 2022 James West, Director in Lincoln’s Healthcare Group, explains the key trends and mergers and acquisitions (M&A) dynamics in the… Read More
Scrip | What Does 2022 Hold For Biopharma?
Originally published by SCRIP on February 8 , 2022. James West, Director in Lincoln’s Healthcare Group shares that there has been increased private equity firm’s interest in the Biopharma space and… Read More
Meet our Senior Team in Healthcare
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Managing Director | Management Board MemberFrankfurt